Regnante Keith — insider trades

Stock trades Regnante Keith reported on SEC Form 4 at KROS Keros Therapeutics, Inc..

• Feb 18, 2026: sold 4,739 shares of KROS Keros Therapeutics, Inc. ($77.5K)